Pfizer, Starboard
Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were 'Threatened'
Key Takeaways Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value.The ex-Pfizer executives, Ian Read and Frank D'Amelio,
Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting with activist investor Starboard Value, Pfizer's former CEO and CFO publicly changed their tune after being threatened with litigation by Pfizer,
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says
Activist Starboard Value accused Pfizer of threatening litigation against two renegade former executives that initially were supportive of the investor's turnaround campaign at the pharmaceutical giant.
Ex-Pfizer execs ‘threatened’ for supporting plans to shake up company, Starboard says
In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.
Pfizer’s stock dips after two former execs say they won’t support Starboard, offer backing for CEO Albert Bourla
Pfizer Inc.’s stock dipped early Thursday, after two of its former executives said they would not support an effort by activist shareholder Starboard Value to orchestrate a turnaround.
Activist Investor Starboard Value Accuses Pfizer Of Pressure Former Execs To Halt Support For Its...
Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt support for Starboard’s turnaround campaign. Starboard’s Jeff Smith revealed the company allegedly threatened to claw back compensation and cancel unvested shares.
https//insights.som.yale.edu9h
What Critics of Pfizer Are Getting Wrong
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
The Washington Post on MSN12h
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
pharmaphorum3d
Starboard claims Pfizer 'threatened' former leaders
In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...
STAT3d
Pharmalittle: We’re reading about alleged Pfizer threats, industry payments to peer reviewers, and more
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
Statement From Former Pfizer CEO Ian Read and Former Pfizer CFO Frank D’Amelio Regarding Starboard Value
Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer CEO Ian Read and former Pfizer CFO Frank D’Amelio: We have decided not to be involved in the efforts of Starboard Value ...
Why Pfizer Stock Popped on Monday
Pfizer ( PFE 3.18%) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...
What's Going On With Pfizer Stock On Thursday?
On Thursday, Starboard Value LP, a significant shareholder of Pfizer Inc. (NYSE:PFE), issued a letter to the company’s Board ...
Former Pfizer Executives Ian Read And Frank D'Amelio Decline Involvement With Starboard's Efforts
Guggenheim Securities, LLC has issued a statement on behalf of former Pfizer Chief Executive Officer Ian Read and former Chief ...
Pfizer faces showdown with $1.5 billion activist investor after post-Covid share plunge
Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...